506 related articles for article (PubMed ID: 38474387)
1. Role of Inflammatory Mechanisms in Major Depressive Disorder: From Etiology to Potential Pharmacological Targets.
Kouba BR; de Araujo Borba L; Borges de Souza P; Gil-Mohapel J; Rodrigues ALS
Cells; 2024 Feb; 13(5):. PubMed ID: 38474387
[TBL] [Abstract][Full Text] [Related]
2. Major Depressive Disorder and Gut Microbiota: Role of Physical Exercise.
Souza PB; de Araujo Borba L; Castro de Jesus L; Valverde AP; Gil-Mohapel J; Rodrigues ALS
Int J Mol Sci; 2023 Nov; 24(23):. PubMed ID: 38069198
[TBL] [Abstract][Full Text] [Related]
3. Anti-inflammatory treatment for major depressive disorder: implications for patients with an elevated immune profile and non-responders to standard antidepressant therapy.
Kopschina Feltes P; Doorduin J; Klein HC; Juárez-Orozco LE; Dierckx RA; Moriguchi-Jeckel CM; de Vries EF
J Psychopharmacol; 2017 Sep; 31(9):1149-1165. PubMed ID: 28653857
[TBL] [Abstract][Full Text] [Related]
4. Major depressive disorder as a neuro-immune disorder: Origin, mechanisms, and therapeutic opportunities.
Réus GZ; Manosso LM; Quevedo J; Carvalho AF
Neurosci Biobehav Rev; 2023 Dec; 155():105425. PubMed ID: 37852343
[TBL] [Abstract][Full Text] [Related]
5. NLRP3 Inflammasome: From Pathophysiology to Therapeutic Target in Major Depressive Disorder.
Kouba BR; Gil-Mohapel J; S Rodrigues AL
Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36613574
[TBL] [Abstract][Full Text] [Related]
6. Peripheral Alterations in Cytokine and Chemokine Levels After Antidepressant Drug Treatment for Major Depressive Disorder: Systematic Review and Meta-Analysis.
Köhler CA; Freitas TH; Stubbs B; Maes M; Solmi M; Veronese N; de Andrade NQ; Morris G; Fernandes BS; Brunoni AR; Herrmann N; Raison CL; Miller BJ; Lanctôt KL; Carvalho AF
Mol Neurobiol; 2018 May; 55(5):4195-4206. PubMed ID: 28612257
[TBL] [Abstract][Full Text] [Related]
7. Platelets bridging the gap between gut dysbiosis and neuroinflammation in stress-linked disorders: A narrative review.
Rust C; Malan-Muller S; van den Heuvel LL; Tonge D; Seedat S; Pretorius E; Hemmings SMJ
J Neuroimmunol; 2023 Sep; 382():578155. PubMed ID: 37523892
[TBL] [Abstract][Full Text] [Related]
8. Soy isoflavones alleviate lipopolysaccharide-induced depressive-like behavior by suppressing neuroinflammation, mediating tryptophan metabolism and promoting synaptic plasticity.
Lu C; Wei Z; Wang Y; Li S; Tong L; Liu X; Fan B; Wang F
Food Funct; 2022 Sep; 13(18):9513-9522. PubMed ID: 35993820
[TBL] [Abstract][Full Text] [Related]
9. Antidepressants, antimicrobials or both? Gut microbiota dysbiosis in depression and possible implications of the antimicrobial effects of antidepressant drugs for antidepressant effectiveness.
Macedo D; Filho AJMC; Soares de Sousa CN; Quevedo J; Barichello T; Júnior HVN; Freitas de Lucena D
J Affect Disord; 2017 Jan; 208():22-32. PubMed ID: 27744123
[TBL] [Abstract][Full Text] [Related]
10. Muscone with Attenuation of Neuroinflammation and Oxidative Stress Exerts Antidepressant-Like Effect in Mouse Model of Chronic Restraint Stress.
Liu H; Liu LL; Chen J; Chen YW; Chai Y; Liu QS; Cheng Y
Oxid Med Cell Longev; 2022; 2022():3322535. PubMed ID: 36211814
[TBL] [Abstract][Full Text] [Related]
11. Peripheral cytokine levels and response to antidepressant treatment in depression: a systematic review and meta-analysis.
Liu JJ; Wei YB; Strawbridge R; Bao Y; Chang S; Shi L; Que J; Gadad BS; Trivedi MH; Kelsoe JR; Lu L
Mol Psychiatry; 2020 Feb; 25(2):339-350. PubMed ID: 31427752
[TBL] [Abstract][Full Text] [Related]
12. Nitric oxide: Antidepressant mechanisms and inflammation.
Ghasemi M
Adv Pharmacol; 2019; 86():121-152. PubMed ID: 31378250
[TBL] [Abstract][Full Text] [Related]
13. Neuroinflammation through the vagus nerve-dependent gut-microbiota-brain axis in treatment-resistant depression.
Hashimoto K
Prog Brain Res; 2023; 278():61-77. PubMed ID: 37414494
[TBL] [Abstract][Full Text] [Related]
14. The effect of antidepressant medication treatment on serum levels of inflammatory cytokines: a meta-analysis.
Hannestad J; DellaGioia N; Bloch M
Neuropsychopharmacology; 2011 Nov; 36(12):2452-9. PubMed ID: 21796103
[TBL] [Abstract][Full Text] [Related]
15. Inflammation and serotonin deficiency in major depressive disorder: molecular docking of antidepressant and anti-inflammatory drugs to tryptophan and indoleamine 2,3-dioxygenases.
Dawood S; Bano S; Badawy AA
Biosci Rep; 2022 May; 42(5):. PubMed ID: 35506370
[TBL] [Abstract][Full Text] [Related]
16. Multi-omics reveal microbial determinants impacting the treatment outcome of antidepressants in major depressive disorder.
Wang Y; Zhou J; Ye J; Sun Z; He Y; Zhao Y; Ren S; Zhang G; Liu M; Zheng P; Wang G; Yang J
Microbiome; 2023 Aug; 11(1):195. PubMed ID: 37641148
[TBL] [Abstract][Full Text] [Related]
17. Antidepressants induce autophagy dependent-NLRP3-inflammasome inhibition in Major depressive disorder.
Alcocer-Gómez E; Casas-Barquero N; Williams MR; Romero-Guillena SL; Cañadas-Lozano D; Bullón P; Sánchez-Alcazar JA; Navarro-Pando JM; Cordero MD
Pharmacol Res; 2017 Jul; 121():114-121. PubMed ID: 28465217
[TBL] [Abstract][Full Text] [Related]
18. Pro-inflammatory cytokines as predictors of antidepressant effects of exercise in major depressive disorder.
Rethorst CD; Toups MS; Greer TL; Nakonezny PA; Carmody TJ; Grannemann BD; Huebinger RM; Barber RC; Trivedi MH
Mol Psychiatry; 2013 Oct; 18(10):1119-24. PubMed ID: 22925832
[TBL] [Abstract][Full Text] [Related]
19. Agmatine as a novel candidate for rapid-onset antidepressant response.
Valverde AP; Camargo A; Rodrigues ALS
World J Psychiatry; 2021 Nov; 11(11):981-996. PubMed ID: 34888168
[TBL] [Abstract][Full Text] [Related]
20. Effects of SSRIs on peripheral inflammatory markers in patients with major depressive disorder: A systematic review and meta-analysis.
Wang L; Wang R; Liu L; Qiao D; Baldwin DS; Hou R
Brain Behav Immun; 2019 Jul; 79():24-38. PubMed ID: 30797959
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
